Skip to content
FDA drug shortage status

Is Glyburide Tablet in shortage?

Glyburide Tablet is listed by FDA as being discontinued by at least one maker (updated Aug 10, 2026).

Being discontinuedFDA status
4packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Diabeta, Tablet, 5 mg (NDC 0093-9364-01)
    Sanofi-Aventis U.S. LLCBeing discontinuedUpdated Aug 10, 2026Discontinued Aug 10, 2026

    A business decision was made to discontinue manufacture of the drug.

    Maker contact: 800-633-1610

  • Diabeta, Tablet, 5 mg (NDC 0093-9364-10)
    Sanofi-Aventis U.S. LLCBeing discontinuedUpdated Aug 10, 2026Discontinued Aug 10, 2026

    A business decision was made to discontinue manufacture of the drug.

    Maker contact: 800-633-1610

  • Diabeta, Tablet, 2.5 mg (NDC 0093-9433-01)
    Sanofi-Aventis U.S. LLCBeing discontinuedUpdated Aug 10, 2026Discontinued Aug 10, 2026

    A business decision was made to discontinue manufacture of the drug.

    Maker contact: 800-633-1610

  • Diabeta, Tablet, 1.25 mg (NDC 0093-9477-53)
    Sanofi-Aventis U.S. LLCBeing discontinuedUpdated Aug 10, 2026Discontinued Aug 10, 2026

    A business decision was made to discontinue manufacture of the drug.

    Maker contact: 800-633-1610

Glyburide Tablet shortage questions

Is Glyburide Tablet in shortage?

Glyburide Tablet is listed by FDA as being discontinued by at least one maker (updated Aug 10, 2026).

What should I do if I can’t get Glyburide Tablet?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.